© 1999 by Oxford University Press
Journal of the National Cancer Institute, Vol. 91, No. 13, 1159-1160,
July 7, 1999
© 1999 Oxford University Press
BRIEF COMMUNICATIONS |
Renal Cell Cancer: Chromosome 3 Translocations as Risk Factors
Affiliations of authors: A. Geurts van Kessel, H. Wijnhoven, D. Bodmer, M. Eleveld, M. Weterman, M. Ligtenberg, D. Smeets, A. Smits (Department of Human Genetics), L. Kiemeney (Departments of Epidemiology and Urology), P. Mulders (Department of Urology), University Hospital Nijmegen, The Netherlands.
Correspondence to: Ad Geurts van Kessel, Ph.D., Department of Human Genetics, University Hospital, P. O. Box 9101, 6500 HB Nijmegen, The Netherlands.
Renal cell cancer (RCC) is relatively rare,
with overall incidence rates of approximately five per 100 000
(1). The disease can be cured only by surgery if detected
early and clinically restricted to the organ, that is, without
metastasis. Usually, RCCs occur as sporadic tumors, but hereditary RCCs
have also been reported in particular as a consequence of von
Hippel-Lindau (VHL) disease (2). Until recently, two families
with RCC and with balanced chromosomal translocations were reported. In
the first family, a constitutional translocation t(3;8)(p14;q24) (i.e.,
a genetic exchange between position p14 of chromosome 3 and position
q24 of chromosome
NOTES
REFERENCES
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Rodriguez-Perales, B. Melendez, S. M. Gribble, L. Valle, N. P. Carter, I. Santamaria, L. Conde, M. Urioste, J. Benitez, and J. C. Cigudosa Cloning of a new familial t(3;8) translocation associated with conventional renal cell carcinoma reveals a 5 kb microdeletion and no gene involved in the rearrangement Hum. Mol. Genet., May 1, 2004; 13(9): 983 - 990. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bodmer, W. van den Hurk, J. J. M. van Groningen, M. J. Eleveld, G. J. M. Martens, M. A. J. Weterman, and A. Geurts van Kessel Understanding familial and non-familial renal cell cancer Hum. Mol. Genet., October 1, 2002; 11(20): 2489 - 2498. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bodmer, M. Eleveld, E. Kater-Baats, I. Janssen, B. Janssen, M. Weterman, E. Schoenmakers, M. Nickerson, M. Linehan, B. Zbar, et al. Disruption of a novel MFS transporter gene, DIRC2, by a familial renal cell carcinoma-associated t(2;3)(q35;q21) Hum. Mol. Genet., March 1, 2002; 11(6): 641 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Takahashi, R Kahnoski, D Gross, D Nicol, and B T Teh Familial adult renal neoplasia J. Med. Genet., January 1, 2002; 39(1): 1 - 5. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-o. Kanayama, W.-O. Lui, M. Takahashi, T. Naroda, D. Kedra, F. K. Wong, Y. Kuroki, Y. Nakahori, C. Larsson, S. Kagawa, et al. Association of a novel constitutional translocation t(1q;3q) with familial renal cell carcinoma J. Med. Genet., March 1, 2001; 38(3): 165 - 170. [Abstract] [Full Text] |
||||

